Literature DB >> 6169541

Fluorescent antibody study of the post-cysticercoid development of Moniezia expansa.

D J Morley, A E Duwe.   

Abstract

The strobila of Moniezia expansa was separated into developmental areas, and these were compared using immunological techniques. Agar double diffusion plates and immunoelectrophoresis showed differing antigenic composition or concentration between the strobilar regions studied. Conjugation of the antisera with rhodamine lissamine-200 aided in localization of common antigens on tissue sections of the various developmental stages. What appeared to be unique localizations were observed.

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6169541     DOI： 10.1007/BF01985701

Source DB:  PubMed          Journal:  Experientia        ISSN： 0014-4754


  6 in total

1.  Antigen-antibody reactions in gels.

Authors:  O OUCHTERLONY
Journal:  Acta Pathol Microbiol Scand       Date:  1949

2.  Echinococcus granulosus: the distribution of hydatid fluid antigens in the tissues of the larval stage. II. Localization of the thermostable lipoprotein of parasitic origin (antigen B).

Authors:  L A Yarzabal; H Dupas; D Bout; F Naquira; A Capron
Journal:  Exp Parasitol       Date:  1977-06       Impact factor: 2.011

3.  Histochemical observations on the tegumentary epithelium and interproglottidal glands of Moniezia expansa (Rud., 1805) (Cestoda, Cyclophyllidea).

Authors:  R E Howells; D A Erasmus
Journal:  Parasitology       Date:  1969-08       Impact factor: 3.234

4.  Antigens of Moniezia expansa: fluorescent antibody localization.

Authors:  A E Duwe
Journal:  Trans Am Microsc Soc       Date:  1967-04

5.  Antigenic analysis of a metazoan parasite, Toxocara canis. I. extraction and assay of antigens.

Authors:  E L Jeska
Journal:  Exp Parasitol       Date:  1967-02       Impact factor: 2.011

6.  Antigenic analysis of developmental stages of Ascaris suum. I. Comparison of eggs, larvae and adults.

Authors:  J F Williams; E J Soulsby
Journal:  Exp Parasitol       Date:  1970-02       Impact factor: 2.011
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.